Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT06387173

Registry of Patients Undergoing Cryoablation for Early Stage Breast Cancer

This study evaluates the side effects and outcomes of patients who undergo cryoablation for early stage breast cancer.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

UCLA / Jonsson Comprehensive Cancer Center

Los Angeles, California, 90095, United States

About this study

PRIMARY OBJECTIVE:

I. To obtain observational real-life data of patients who choose this non-conventional treatment and to follow their outcomes.

OUTLINE: This is an observational study.

Patients have their medical records reviewed on study.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients undergoing cryoablation for breast cancer

Treatment and study plan

Non-Interventional Study

Other

Non-interventional study

Primary outcomes

  1. Prospectively track patients who undergo cryoablation for breast cancer and record post-treatment related events.

    Time frame: five years from last participant enrollment

    record follow up of symptoms, reported complications, breast imaging findings, and results of any future biopsies related to cancer, and treatment of breast cancer.

Sponsors and collaborators

Lead sponsor

Jonsson Comprehensive Cancer Center

Other

Registry information

Important dates

Study start
2024
Primary completion
2027
Study completion
2099
First posted
Apr 26, 2024
Registry last updated
May 11, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.